In this Voices on Cancer blog post, prostate cancer advocate Dennis Golden describes his cancer experience and how he put his professional skills to work advancing his advocacy mission.
In this podcast, Dr. Sumanta Pal gives an overview of research that will be shared at the 2017 Genitourinary Cancers Symposium.
Identifying genetic changes has given us new insights in early detection and treatment of advanced and castration-resistant prostate cancer.
It takes a lot of courage to overcome embarrassment and discomfort, especially when it comes to sexual health. But doing so can lead to happy outcomes.
Active surveillance and watchful waiting are 2 prostate cancer treatments that people often confuse. Pathologist Oleksandr N. Kryvenko, MD, FCAP, explains exactly what they are and who may benefit from them.
Sumanta Pal, MD, discusses one study on aspirin and prostate cancer highlighted at the 2016 Genitourinary Cancers Symposium.
In this podcast, Leslie R. Schover, PhD, discusses the sexual concerns that often come with hormone therapy for prostate cancer.
Two out of three people now live at least five years after being diagnosed with cancer, but there is still more to be done. Researchers at the 2015 ASCO Annual Meeting showed how new treatment options can continue to improve and lengthen the lives of people with both rare and common cancers.
Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.
Study Shows a Certain Type of Baldness at Age 45 May Increase the Risk for Aggressive Prostate Cancer
Men who have lost their hair at the front and top of their heads at age 45 have a 40% increased risk of developing faster-growing prostate cancer later in life.